| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |